Farmeconomia: Health Economics and Therapeutic Pathways (Sep 2008)

Abruzzo

  • Maria Caterina Cavallo,
  • Filippo Cipriani,
  • Simone Gerzeli,
  • Nadia Demarteau,
  • Alessia Marocco,
  • Francesco Bamfi

DOI
https://doi.org/10.7175/fe.v9i1S.1012
Journal volume & issue
Vol. 9, no. 1S
pp. 63 – 65

Abstract

Read online

In Abruzzo region 55,4% of women (aged 25-64) are screened regularly, meaning every 3 years. Considering regional tariffs and vaccine acquisition cost, the vaccination of 12-year-old girls with a 90% coverage could prevent 29 cases of cervicocarcinoma and 12 related deaths and thus results to be cost-effective (20.836 €/QALY). When the vaccination programme is extended to 16-year-old girls a further 28 cancer cases and 12 deaths could be prevented, with a very similar cost-effectiveness ratio. In Abruzzo region, the net cost for woman vaccinated is 199 € for the single cohort and 202 € for the multiple cohort.

Keywords